$2,085 – $6,275

8th KOL/Thought Leader Engagement and Advisory Boards Summit (EXL)

Event Information

Share this event

Date and Time

Location

Location

Sonesta Philadelphia Rittenhouse Square

1800 Market Street

Philadelphia, PA 19103

View Map

Friends Who Are Going
Event description

Description

8th KOL/Thought Leader Engagement and Advisory Boards Summit

Conference Chairs

Conference Chair


Aleksandra Vlajnic, M.D., MBA, Vice President, US Medical Affairs, General Medicine, Hematology and Dermatology, BAYER

Corporate Strategy Track Chair


John Sears, Ph.D., MBA, Director, Health Care Quality Strategy for Cardiovascular and Metabolics, JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC.

Field Strategy Track Chair


Nelson G. Costa, Director, Migraine KOL and Advocacy Marketing, AVANIR


The 8th KOL/Thought Leader Engagement & Advisory Boards Summit is the premier event that showcases the best strategies for collaboration on the identification, engagement and management of therapeutic area experts that can assist an organization throughout a product’s life cycle. These experts — commonly referred to as thought leaders or key opinion leaders — will provide industry professionals with valuable insight that will allow them to engage with KOLs compliantly, including declaring all payments through the aggregate spend guidelines.

The acquisition of medical and scientific information, combined with transparent, compliant compensation for advisory board participation, serves as key themes for this conference in an environment where industry professionals are engaging traditional KOLs as well as new thought leaders.

Speakers


Sherrie Smartt, Medical Director, Clinical Studies and Regulatory Affairs Manager, THERMO FISHER SCIENTIFIC
Peter Lee, Vice
President, Compliance, HERON THERAPEUTICS
Mary Chi Michael, Vice President, Patient Advocacy and Stakeholder Management, OTSUKA

Sudeesh K. Tantry, Ph.D., Vice President, Clinical Development, GLENMARK PHARMACEUTICALS
James Stec, Senior
Director, Medical Affairs, IMMUNOGEN
David Lee Scher, M.D., FACP, FACC, FHRS, Cardiologist; Director, DLS HEALTHCARE CONSULTING

Top Five Reasons to Attend

  1. Discuss the acquisition and management of medical information and how to properly disseminate it to a host organization
  2. Discover technological innovations in KOL mapping, advisory board management and thought leader identification
  3. Exchange best practices with industry professionals, both commercial and clinical, on managing thought leader relationships and cross-functional information sharing
  4. Interact with physicians to understand how they best want to be engaged and participate in advisory boards
  5. Utilize disruptive techniques to engage with thought leaders while providing them value and key tools

Who Should Attend:

This conference is designed for representatives from pharmaceutical, biotechnology and medical device companies with responsibilities in the following areas:

  • KOL Relationship Management/Development
  • Opinion/Thought Leader Relations
  • Medical Science Liaisons
  • Brand/Product Management
  • Medical and Professional Affairs
  • Medical and Professional Education
  • Advisory Board Management
  • Speaker Bureau Training/Management
  • Speaker Programs
  • Professional Education/Programs
  • Global Relations
  • Compliance, Legal and Regulations
  • Scientific/Medical Communication, Relations and Affairs
  • Business Development
  • CRM Systems
  • Sales and Marketing
  • Professional Relations
  • External Affairs
  • Stakeholder Relations/Outreach
  • Medical Publications
  • Physician Education/Outreach
  • Promotional Regulatory Affairs
  • Government Relations/Affairs

This conference is also of interest to:

  • KOL Management, Social Network Analysis (SNA) and KOL Identifiers
  • KOL Technology/Software Providers
  • KOL Identification and Mapping Services
  • Digital Advisory Board Service Providers
  • Conferencing Software Providers
  • Communication and Public Speaking Bureaus
  • Law Firms
  • Aggregate Spend Professionals

Agenda

Main Conference Day One

Thursday, June 15, 2017

8:00 – 8:45

Registration and Continental Breakfast

8:45 – 9:00

Chairperson’s Opening Remarks

Aleksandra Vlajnic, M.D., MBA, Vice President, US Medical Affairs, General Medicine, Hematology and Dermatology, BAYER

9:00 – 9:45

Who Are the Thought Leaders of Today and How Can You Engage Them in a Meaningful Way?

Mary Chi Michael, Vice President, Patient Advocacy and Stakeholder Management, OTSUKA

9:45 – 10:30

Health Check: Assess and Improve Your KOL/ Thought Leader Approach

Jeff Sears, Executive Director, AVANT HEALTHCARE

10:30 – 11:00

Networking Break

11:00 – 11:45

Attribute Value to Field Team Interactions Through Meaningful Metrics and KPIs

Aleksandra Vlajnic, M.D., MBA, Vice President, US Medical Affairs, General Medicine, Hematology and Dermatology, BAYER

11:45 – 12:30

The Challenges of Preparing the Market for a Product Launch at a Small Biotech

James Stec, Senior Director, Medical Affairs, IMMUNOGEN

12:30 – 1:30

Luncheon

1:30 – 2:15

What Does KOL Engagement Look Like in the Digital Era?

David Lee Scher, M.D., FACP, FACC, FHRS, Cardiologist; Director, DLS HEALTHCARE CONSULTING

2:15 – 3:00

Effectively Tier Thought Leaders to Determine the Fair Market Value of Payments

Kevin Ryan, Senior Director, Risk and Accountability, NOVO NORDISK

3:00 – 3:30

Networking Break

3:30 – 4:15

Case Study: Examine the Development of a Centralized Customer Engagement Team

Vimal Patel, Senior Director, Customer Engagement, SUN PHARMA

4:15 – 5:00

Panel: Best Practices for Developing a Brand Strategy Across Medical and Commercial Groups that Aligns with an Organization’s Business Objectives

Vimal Patel, Senior Director, Customer Engagement, SUN PHARMA
Peter Lee, Vice President, Compliance, HERON THERAPEUTICS
Jacqueline S. Armani, O.D., FAAO, Medical Science Liaison – Surgical, ALCON

5:00 – 5:45

Optimize Stakeholder Engagement Programs with Online Discussion Platforms

Lance Hill, CEO, WITHIN3

5:45 –

Day One Concludes


Main Conference Day Two

Friday, June 16, 2017

8:00 – 9:00

Continental Breakfast

CORPORATE STRATEGY

9:00 – 9:15
Chairperson’s Opening Remarks and Recap of Day One

John Sears, Ph.D., MBA, Director, Health Care Quality Strategy for Cardiovascular and Metabolics, JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC.

9:15 – 10:00
Do More with Less Using Data-Driven Engagement Strategies

Tony Page, Chief Executive Officer, VOXX ANALYTICS

10:00 – 10:45
Case Study: Develop an Effective Strategy to Help Focus the Efforts of Your Field Team and Avoid Overlap with Commercial

Sherrie Smartt, RN, MSN, MHA, Medical Director, Clinical Studies and Regulatory Affairs Manager, THERMO FISHER SCIENTIFIC

FIELD STRATEGY

9:00 – 9:15
Chairperson’s Opening Remarks and Recap of Day One

Nelson G. Costa, Director, Migraine KOL and Advocacy Marketing, AVANIR

9:15 – 10:00
KOL Development and Engagement Plan for Effective Partnerships

Nelson G. Costa, Director, Migraine KOL and Advocacy Marketing, AVANIR

10:00 – 10:45
KOL Mapping to Optimize Medical Communications and the Field Force: A Revolutionary Approach

Badal Shah, B.Pharm, M.S., MBA, Director, Health Analytics, QPHARMA

10:45 – 11:15

Networking Break

CORPORATE STRATEGY

11:15 – 12:00
What to Do and Not to Do When Running an Advisory Board

Bob Numerof, MSL Field Team Leader, US Medical Affairs, CSL BEHRING

FIELD STRATEGY

11:15 – 12:00
Learn How to Build a Successful Clinical Workshop for Implementing Products

Brad P. Mayeux, MSN, RN, Manager, Medical and Scientific Affairs, Cardiac Biomarkers, ROCHE DIAGNOSTICS

12:00 – 1:15

Luncheon

CORPORATE STRATEGY

1:15 – 2:00
Reimagine the KOL

John Sears, Ph.D., MBA, Director, Health Care Quality Strategy for Cardiovascular and Metabolics, JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC.

2:00 – 2:45
A Compliance Perspective on Effective Advisory Board/Consulting Arrangement Execution

Peter Lee, Vice President, Compliance, HERON THERAPEUTICS

2:45 – 3:30
Panel: Best Practices for Managing Successful Advisory Boards

Bob Numerof, MSL Field Team Leader, US Medical Affairs, CSL BEHRING
James Stec, Senior Director, Medical Affairs, IMMUNOGEN

3:30 – 3:45
Chairperson’s Closing Remarks

FIELD STRATEGY

1:15 – 2:00
Case Study: Raise Awareness About the Underrepresentation of Women in Cardiovascular Clinical Trials

Margaret A. Campbell, Pharm.D., Medical Science Liaison, Director, USMedical Cardio-Respiratory Medical Unit, NOVARTIS

2:00 – 2:45
Implement and Quantify an Effective MSL Strategy Relating to KOL Engagement

James Hopper, MBA, BSN, Clinical Operations Manager, North America Clinical Diagnostics, THERMO FISHER SCIENTIFIC
Maureen Turner, RN, Medical Science Liaison, THERMO FISHER SCIENTIFIC

2:45 – 3:30
KOL Engagement and Advisory Board Interactions During Early Phase Product Development

Sudeesh K. Tantry, Ph.D., Vice President, Clinical Development, GLENMARK PHARMACEUTICALS

3:30 – 3:45
Chairperson’s Closing Remarks

3:45 –

Conference Concludes


Faculty


Jacqueline S. Armani, O.D., FAAO
Medical Science Liaison –Surgical, ALCON


Margaret A. Campbell, Pharm.D.
Medical Science Liaison, Director, US Medical Cardio-Respiratory Medical Unit, NOVARTIS

Nelson G. Costa
Director, Migraine KOL and Advocacy Marketing, AVANIR


Lance Hill
Chief Executive Officer, WITHIN3


Lance Hill, Chief Executive Officer, WITHIN 3

James Hopper, MBA, BSN
Clinical Operations Manager, North America Clinical Diagnostics, THERMO FISHER SCIENTIFIC

Peter Lee
Vice President, Compliance, HERON THERAPEUTICS


Peter Lee, Senior Director, Healthcare Compliance, PHARMACYCLICS

Brad Mayeux
Manager of Medical and Scientific Affairs – Cardiac, ROCHE


Mary Chi Michael
Vice President, Patient Advocacy and Stakeholder Management, OTSUKA


Bob Numerof
MSL Field Team Leader, US Medical Affairs, CSL BEHRING


Robert Numerof, Senior Director, Global Medical Affairs, BAXTER HEALTHCARE

Tony Page
Chief Executive Officer, VOXX ANALYTICS


Tony Page, Chief Executive Officer, VOXX ANALYTICS

Kevin Ryan
Senior Director, Risk and Accountability, NOVO NORDISK


David Lee Scher, M.D., FACP, FACC, FHRS
Cardiologist; Director, DLS HEALTHCARE CONSULTING


Jeff Sears
Executive Director, AVANT HEALTHCARE


John Sears, Ph.D., MBA
Director, Health Care Quality Strategy for Cardiovascular and Metabolics, JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC.


Badal Shah, B.Pharm, M.S. MBA
Director, Health Analytics, QPHARMA


Sherrie Smartt, RN, MSN, MHA
Medical Director, Clinical Studies and Regulatory Affairs Manager, THERMO FISHER SCIENTIFIC


James Stec, MS
Senior Director, Medical Affairs, IMMUNOGEN


Sudeesh K. Tantry, Ph.D.
Vice President, Clinical Development, GLENMARK PHARMACEUTICALS


Aleksandra Vlajnic, M.D., MBA
Vice President, US Medical Affairs, General Medicine, Hematology and Dermatology, BAYER




Please contact the event manager Marilyn below for the following:
- Discounts for registering 5 or more participants.
- If you company requires a price quotation.
Event Manager Contact: marilyn.b.turner(at)nyeventslist.com
You can also contact us if you require a visa invitation letter, after ticket purchase.
We can also provide a certificate of completion for this event if required.

NO REFUNDS OR TRANSFER ALLOWED ON REGISTRATIONS
-----------------------------------------------------------------
This Event Listing is Promoted by
New York Media Technologies LLC in association
with EXL Events Inc.
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------

SHU170502CEV

Share with friends

Date and Time

Location

Sonesta Philadelphia Rittenhouse Square

1800 Market Street

Philadelphia, PA 19103

View Map

Save This Event

Event Saved